Login

Mr. Nitin Verma, CEO of Mirae Asset Global Indices, unveils the future of ETFs at Innowave. 00:10:00

Share On Facebook Share On Twitter

Kim, Mi Seob · President & CEO, Mirae Asset Global Investments

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Insurance Quick Takes: Tim Antonelli on the Future of US Insurance Climate Risk Oversight
00:10:00
Pierre Barnabé from Soitec aims to triple the company's presence in smartphones.
00:00:00
"Treating Rare Diseases" – Soligenix, Inc.'s interview - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:10:00
Kelly Malcolm on Amex Exploration's Ambitious Drilling Program and High-Grade Gold Discoveries in Quebec
00:10:00
Yes Bank Strengthens Balance Sheet with ₹15,000 Crore FPO, Eyes Future Growth | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
Optimistic Outlook for M&A Activity in the TMT Sector in 2014
00:10:00
During a post-NRF 2022 panel, VTEX Co-CEO and cofounder Mariano Gomide de Faria discusses entrepreneurship with David Schonthal.
00:10:00
Argenica Therapeutics CEO Dr. Liz Dallimore Discusses Development Pathway of ARG-007 | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
ActiveOps IPO Launch: CEO Richard Jeffery on Growth and Shareholder Returns | Richard Jeffery, CEO, ActiveOps Plc.
00:00:00
Stuart Quin Chief Executive Officer, Medica Group
00:10:00
CoreSafe at Work: Fosterville Gold Mine's Core Tray System in Action | JESSICA KEAST , DIRECTOR of CoreSafe Core Trays
00:10:00
Mastering Alpha Creation: An Exclusive Conversation with Sunil Singhania, Founder of Abakkus Asset Management LLP on ICICI Direct

© 2026 Nehu